Correlation Between CSL and Nascent Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CSL and Nascent Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Nascent Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL and Nascent Biotech, you can compare the effects of market volatilities on CSL and Nascent Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Nascent Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Nascent Biotech.

Diversification Opportunities for CSL and Nascent Biotech

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between CSL and Nascent is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding CSL and Nascent Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nascent Biotech and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with Nascent Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nascent Biotech has no effect on the direction of CSL i.e., CSL and Nascent Biotech go up and down completely randomly.

Pair Corralation between CSL and Nascent Biotech

Assuming the 90 days horizon CSL is expected to under-perform the Nascent Biotech. But the pink sheet apears to be less risky and, when comparing its historical volatility, CSL is 73.66 times less risky than Nascent Biotech. The pink sheet trades about -0.17 of its potential returns per unit of risk. The Nascent Biotech is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  6.20  in Nascent Biotech on December 3, 2024 and sell it today you would lose (5.45) from holding Nascent Biotech or give up 87.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.39%
ValuesDaily Returns

CSL  vs.  Nascent Biotech

 Performance 
       Timeline  
CSL 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days CSL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Nascent Biotech 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nascent Biotech are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Nascent Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

CSL and Nascent Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CSL and Nascent Biotech

The main advantage of trading using opposite CSL and Nascent Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Nascent Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nascent Biotech will offset losses from the drop in Nascent Biotech's long position.
The idea behind CSL and Nascent Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges